UF Center for Drug Evaluation and Safety

🔷UPDATE🔷 CoDES will be transitioning from X to LinkedIn! Please follow our LinkedIn account for updates on our latest research, news, and more! As always, we look forward to continuing to translate big data into even bigger, healthier and safer outcomes! linkedin.com/company/ufcodes

POP graduate student Henry Hung-Kai Chen places third in student abstract competition at ISPE Annual Meeting pharmacy.ufl.edu/2024/09/23/pop…

UF Health researchers receive NIH R01 grant to develop social risk management tool for people living with dementia @Serena_JG pharmacy.ufl.edu/2024/10/17/uf-…

New publication by @UFCoDES trainee @SJugl1 in @LiebertPub –Legalization of Smokable Medical Cannabis and Changes in the Dispensed Amount of Δ-9 Tetrahydrocannabinol Per Patient | Cannabis and Cannabinoid Research liebertpub.com/doi/full/10.10… @amiegoodin @AlmutWinterste1

New publication by @AlmutWinterste1 and @Serena_JG in @IntPharmacoEpi Using machine learning to identify diabetes patients with canagliflozin prescriptions at high-risk of lower extremi… pubmed.ncbi.nlm.nih.gov/33606340/ @UFPharmacy

New publication by @UFCoDES trainee @TangHuilin in @BioMedCentral – Association of education attainment, smoking status, and alcohol use disorder with dementia risk in older adults: a… pubmed.ncbi.nlm.nih.gov/39294787/ @Serena_JG @UFPharmacy

New publication by @Serena_JG in Diabetes, Obesity and Metabolism – Sodium-glucose cotransporter 2 inhibitors and the risk of #Parkinson disease in real-world patients with type 2 diabetes pubmed.ncbi.nlm.nih.gov/39256938/ @UFPharmacy

New publication co-authored by @segal_rich in @ADCESdiabetes Medication Engagement, Determinants of Health, and A1C Levels Among Adults With Type 2 Diabetes within a Tribal Health System journals.sagepub.com/doi/full/10.11… @UFPharmacy

New publication by @UFCoDES trainee @tSHCw in @amcporg– Cost-effectiveness of early vs delayed use of abemaciclib combination therapy for patients with high-risk hormone receptor–positive/human epidermal growth factor... jmcp.org/doi/10.18553/j…

New publication by @UFCoDES trainee @RiazMunaza in @JInternMed– Hospitalization after #hydroxychloroquine initiation in patients with heart failure with preserved #ejection fraction… pubmed.ncbi.nlm.nih.gov/39193799/ @UFPharmacy

New publication by @UFCoDES trainee @TangHuilin in @movedisorder Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population‐Based Cohort Studyhttps://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.29992

New publication by @UFCoDES trainee @GraceWahaha in @JAMANetworkOpen #Injurious Fall Risk Differences Among Older Adults Being Treated for #Depression jamanetwork.com/journals/jaman… @jennyciganic @amiegoodin @UFPharmacy

New publication co-authored by @SteveSmithUF in @AMIAinformatics - Characterizing apparent treatment resistant hypertension in the United States: insights from the All of Us Research Program academic.oup.com/jamia/article-… @UFPharmacy

New publication co-authored by @AlmutWinterste1 in @ASCPT_ClinPharm – Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators ascpt.onlinelibrary.wiley.com/doi/full/10.11… @UFPharmacy

New publication co-authored by @AlmutWinterste1 in @ASCPT_ClinPharm -Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry – Informing optimal antiplatelet strategies ascpt.onlinelibrary.wiley.com/doi/10.1111/ct… @UFPharmacy

New publication co-authored by @Serena_JG in American Journal of Cardiovascular Drugs –#COVID-19 Diagnosis, Oral #Anticoagulation, and #Stroke Risk in Patients with Atrial Fibrillation pubmed.ncbi.nlm.nih.gov/39136872/ @UFPharmacy

New publication by @amiegoodin in @IntPharmacoEpi – Risk of #Suicidal Ideation and Behavior Following Early-Onset #Idiopathic Restless Legs Syndrome Treatment pubmed.ncbi.nlm.nih.gov/39099262/ @UFPharmacy

New publication by @AlmutWinterste1 @amiegoodin in @KargerPublisher – Reasons for Use and Perceived Effects of #Medical #Cannabis: A Cross-Sectional Statewide Survey karger.com/mca/article/7/… @UFPharmacy

Dr. Riaz’s heart failure study was recognized at the 2024 ISPOR Conference. @RiazMunaza, Ph.D., is a 2023 graduate of the University of Florida College of Pharmacy’s department of pharmaceutical outcomes and policy. @UFPharmacy

The University of Florida College of Pharmacy- Department of Pharmaceutical Outcomes & Policy congratulates @SteveSmithUF who was promoted to associate professor on July 1, 2024. @UFPharmacy